• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清肌酐与胱抑素 C 比值可预测非透析慢性肾脏病患者的骨骼肌量和肌力。

Serum creatinine to cystatin C ratio predicts skeletal muscle mass and strength in patients with non-dialysis chronic kidney disease.

机构信息

Division of Nephrology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, 97004, Taiwan; Department of Public Health, Tzu Chi University, Hualien, 97004, Taiwan.

Department of Public Health, Tzu Chi University, Hualien, 97004, Taiwan.

出版信息

Clin Nutr. 2020 Aug;39(8):2435-2441. doi: 10.1016/j.clnu.2019.10.027. Epub 2019 Nov 1.

DOI:10.1016/j.clnu.2019.10.027
PMID:31732290
Abstract

BACKGROUND & AIMS: Muscle wasting is highly prevalent in patients with chronic kidney disease (CKD). However, the assessment of skeletal muscle mass and strength in clinical settings is not commonly available. We aimed to evaluate the feasibility of serum creatinine/cystatin C (Cr/CysC) ratio in the assessment of muscle wasting.

METHODS

In 272 patients with CKD aged 66.5 ± 15.1 years, skeletal muscle mass and handgrip strength (HGS) were assessed. Skeletal muscle index (SMI) was calculated as skeletal muscle mass/height. Low muscle mass was defined as SMI below the sex-specific 10th percentile of study population and low handgrip strength as less than 26 Kg for men and 18 Kg for women.

RESULTS

The Cr/CysC ratio was significantly lower in both the low SMI and low HGS groups. Moreover, the Cr/CysC ratio correlated with SMI (r = .306, p < .001) and HGS (r = .341, p < .001). After adjusting for confounding factors, age, sex, waist circumference, body fat mass, and Cr/CysC ratio were independently associated with SMI, whereas age, sex, diabetes, hemoglobin, estimated glomerular filtration rate, urine protein/creatinine ratio, SMI, and Cr/CysC ratio were independently associated with HGS.

CONCLUSIONS

Cr/CysC ratio appears to be a promising surrogate marker for detecting muscle wasting in patients with CKD. Further studies are needed to extend our findings.

摘要

背景与目的

肌肉减少症在慢性肾脏病(CKD)患者中非常普遍。然而,在临床环境中评估骨骼肌质量和力量并不常见。我们旨在评估血清肌酐/胱抑素 C(Cr/CysC)比值评估肌肉减少症的可行性。

方法

在 272 名年龄为 66.5±15.1 岁的 CKD 患者中,评估了骨骼肌质量和手握力(HGS)。通过骨骼肌质量/身高计算骨骼肌指数(SMI)。低肌肉质量定义为 SMI 低于研究人群的性别特异性第 10 百分位数,低手握力定义为男性低于 26kg 和女性低于 18kg。

结果

低 SMI 和低 HGS 组的 Cr/CysC 比值均显著降低。此外,Cr/CysC 比值与 SMI(r=.306,p<.001)和 HGS(r=.341,p<.001)相关。调整混杂因素后,年龄、性别、腰围、体脂肪量和 Cr/CysC 比值与 SMI 独立相关,而年龄、性别、糖尿病、血红蛋白、估计肾小球滤过率、尿蛋白/肌酐比值、SMI 和 Cr/CysC 比值与 HGS 独立相关。

结论

Cr/CysC 比值似乎是一种有前途的替代标志物,可用于检测 CKD 患者的肌肉减少症。需要进一步的研究来扩展我们的发现。

相似文献

1
Serum creatinine to cystatin C ratio predicts skeletal muscle mass and strength in patients with non-dialysis chronic kidney disease.血清肌酐与胱抑素 C 比值可预测非透析慢性肾脏病患者的骨骼肌量和肌力。
Clin Nutr. 2020 Aug;39(8):2435-2441. doi: 10.1016/j.clnu.2019.10.027. Epub 2019 Nov 1.
2
A new index based on serum creatinine and cystatin C is useful for assessing sarcopenia in patients with advanced cancer.基于血清肌酐和胱抑素 C 的新指标可用于评估晚期癌症患者的肌肉减少症。
Nutrition. 2021 Feb;82:111032. doi: 10.1016/j.nut.2020.111032. Epub 2020 Oct 12.
3
Ratio of serum creatinine to cystatin C is related to leg strength in predialysis CKD patients.血清肌酐与胱抑素 C 的比值与透析前 CKD 患者的腿部力量有关。
Clin Exp Nephrol. 2021 Oct;25(10):1079-1086. doi: 10.1007/s10157-021-02050-7. Epub 2021 Aug 3.
4
Creatinine/(cystatin C × body weight) ratio is associated with skeletal muscle mass index.肌酸酐/(胱抑素 C×体重)比值与骨骼肌质量指数相关。
Endocr J. 2020 Jul 28;67(7):733-740. doi: 10.1507/endocrj.EJ19-0542. Epub 2020 Mar 26.
5
Novel equations incorporating the sarcopenia index based on serum creatinine and cystatin C to predict appendicular skeletal muscle mass in patients with nondialysis CKD.新型方程纳入了基于血清肌酐和胱抑素 C 的肌少症指数,以预测非透析 CKD 患者的四肢骨骼肌量。
Clin Nutr. 2024 Mar;43(3):765-772. doi: 10.1016/j.clnu.2024.01.029. Epub 2024 Feb 1.
6
Serum creatinine/cystatin C ratio as a surrogate marker for sarcopenia in patients with chronic obstructive pulmonary disease.血清肌酐/胱抑素 C 比值作为慢性阻塞性肺疾病患者肌少症的替代标志物。
Clin Nutr. 2021 Mar;40(3):1274-1280. doi: 10.1016/j.clnu.2020.08.010. Epub 2020 Aug 19.
7
Low glomerular filtration rate as an associated risk factor for sarcopenic muscle strength: is creatinine or cystatin C-based estimation more relevant?低肾小球滤过率作为肌肉减少性肌力的相关危险因素:基于肌酐还是胱抑素C的估计更具相关性?
Aging Male. 2017 Jun;20(2):110-114. doi: 10.1080/13685538.2016.1225032. Epub 2016 Sep 20.
8
Decreased the creatinine to cystatin C ratio is a surrogate marker of sarcopenia in patients with type 2 diabetes.肌酐与胱抑素 C 比值降低是 2 型糖尿病患者肌少症的替代标志物。
Diabetes Res Clin Pract. 2018 May;139:52-58. doi: 10.1016/j.diabres.2018.02.025. Epub 2018 Feb 27.
9
Estimation of Muscle Mass Using Creatinine/Cystatin C Ratio in Japanese Community-Dwelling Older People.日本社区居住老年人中使用肌酐/胱抑素C比值估算肌肉量
J Am Med Dir Assoc. 2022 May;23(5):902.e21-902.e31. doi: 10.1016/j.jamda.2021.07.029. Epub 2021 Aug 23.
10
Serum creatinine/cystatin C ratio as a surrogate marker for sarcopenia in patients with gastric cancer.血清肌酐/胱抑素 C 比值作为胃癌患者肌少症的替代标志物。
BMC Gastroenterol. 2022 Jan 19;22(1):26. doi: 10.1186/s12876-022-02093-4.

引用本文的文献

1
Effect of discrepancy in estimated renal function on vancomycin area under the blood concentration-time curve: a retrospective cohort study comparing serum creatinine and serum cystatin C.估算肾功能差异对万古霉素血药浓度-时间曲线下面积的影响:一项比较血清肌酐和血清胱抑素C的回顾性队列研究
Int J Clin Pharm. 2025 Jul 9. doi: 10.1007/s11096-025-01960-w.
2
Risk Factors and Predictive Models for Sarcopenia in Older Adults.老年人肌肉减少症的风险因素及预测模型
Aging Med (Milton). 2025 Apr 18;8(3):192-199. doi: 10.1002/agm2.70012. eCollection 2025 Jun.
3
Creatinine-to-cystatin C ratio and all-cause and cardiovascular mortality in U.S. adults with nonalcoholic fatty liver disease: a nationwide cohort study.
美国非酒精性脂肪性肝病成年人中肌酐与胱抑素C比值及全因死亡率和心血管死亡率:一项全国性队列研究
Front Nutr. 2025 Jun 3;12:1587757. doi: 10.3389/fnut.2025.1587757. eCollection 2025.
4
Effectiveness of sarcopenia screening indicators in predicting death in older patients with chronic heart failure.肌少症筛查指标对老年慢性心力衰竭患者死亡的预测效能
BMC Geriatr. 2025 Jun 4;25(1):406. doi: 10.1186/s12877-025-06069-3.
5
Association between serum creatinine/cystatin C ratio and symptomatic knee osteoarthritis incidents in Chinese middle-aged and older adults, considering sex variations: findings from the CHARLS.考虑性别差异:中国中老年人群血清肌酐/胱抑素C比值与有症状膝关节骨关节炎发病的关联——基于中国健康与养老追踪调查(CHARLS)的发现
Clin Rheumatol. 2025 Jun 3. doi: 10.1007/s10067-025-07517-6.
6
Association Between the Serum Creatinine to Cystatin C Ratio and Cardiovascular Disease in Middle-Aged and Older Adults in China: A Nationwide Cohort Study.中国中老年人群血清肌酐与胱抑素C比值与心血管疾病的关联:一项全国性队列研究
J Am Heart Assoc. 2025 May 6;14(9):e040050. doi: 10.1161/JAHA.124.040050. Epub 2025 Apr 25.
7
Association between sarcopenia index and the risk of second hip fracture in older adults.老年人体成分减少指数与二次髋部骨折风险之间的关联。
J Nutr Health Aging. 2025 Jun;29(6):100532. doi: 10.1016/j.jnha.2025.100532. Epub 2025 Mar 12.
8
Quality matters: chronic kidney disease progression is associated with reduced muscle strength independently of changes in skeletal muscle mass: an observational study.质量很重要:慢性肾病进展与肌肉力量降低相关,独立于骨骼肌质量的变化:一项观察性研究。
Clin Kidney J. 2025 Feb 4;18(3):sfaf036. doi: 10.1093/ckj/sfaf036. eCollection 2025 Mar.
9
Sex-specific prognostic utility of the sarcopenia index in all-cause mortality risk for patients with heart failure.肌肉减少症指数在心力衰竭患者全因死亡风险中的性别特异性预后效用。
Front Nutr. 2025 Feb 19;12:1472596. doi: 10.3389/fnut.2025.1472596. eCollection 2025.
10
A framework of biomarkers for skeletal muscle aging: a consensus statement by the Aging Biomarker Consortium.骨骼肌衰老生物标志物框架:衰老生物标志物联盟的共识声明
Life Med. 2025 Jan 26;3(6):lnaf001. doi: 10.1093/lifemedi/lnaf001. eCollection 2024 Dec.